Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12076411 Anti-HER2 antibody-maytansine conjugates and methods of use thereof

Patent 12076411 was granted and assigned to Redwood Bioscience on September, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Redwood Bioscience

Date Filed

July 22, 2021

Date of Patent

September 3, 2024

Patent Applicant

Redwood Bioscience

Patent Application Number

17383076

Patent Citations

‌

US Patent 9540438 Aldehyde-tagged immunoglobulin polypeptides and methods of use thereof

‌

US Patent 11097013 Anti-HER2 antibody-maytansine conjugates and methods of use thereof

‌

US Patent 9833515 Hydrazinyl-indole compounds and methods for producing a conjugate

‌

US Patent 7585491 Immunoconjugates with an intracellularly-cleavable linkage

‌

US Patent 7985783 Aldehyde tags, uses thereof in site-specific protein modification

‌

US Patent 8729232 Aldehyde tags, uses thereof in site-specific protein modification

‌

US Patent 9310374 Hydrazinyl-indole compounds and methods for producing a conjugate

‌

US Patent 9493413 Hydrazinyl-pyrrolo compounds and methods for producing a conjugate

Patent Inventor Names

Albert W. Garofalo

Jesse M. McFarland

Romas Alvydas Kudirka

Robyn M. Barfield

Aaron Edward Albers

Gregory W. deHart

Penelope M. Drake

David Rabuka

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12076411

Patent Primary Examiner

CPC Code

Find more entities like US Patent 12076411 Anti-HER2 antibody-maytansine conjugates and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.